Drugs · acquisition-cost intelligence
furosemide
· ingredient furosemide· FUROSEMIDE 10 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.34173
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 5 weeks.
2025-07-232026-05-20
Same-ingredient options by acquisition cost
Other furosemide products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| UDSx Medicated System | $0.02961 | −$0.31210 |
| Lasix | $0.03173 | −$0.31000 |
| Furosemide | $0.09404 | −$0.24770 |
| furosemide | $0.37859 | +$0.03690 |
| furosemide | $0.41545 | +$0.07370 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.